Open an account

DaVita

DVA · NYSE

$175.35−$11.65 (−6.23%)TodayMarket closed ·
Prev close $187.00

About DVA

DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 78,000 full-time employees. The firm is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

Employees
78,000
Headquarters
Denver, Colorado
Listed
Oct 31, 1995
Sector
Health Care
Industry
Health Care Providers & Services
Website
davita.com

DVA key statistics

Market cap
11.19B
Price-earnings ratio
15.39
Dividend yield
—
Average volume
529.30K
Volume
2.07M
Open price
$189.31
High today
$191.20
Low today
$171.09
52 Week high
$247.49
52 Week low
$101.00

DaVita (DVA) at a glance

DaVita (DVA) last traded at $175.35, with a market cap of 11.19B and a price-to-earnings ratio of 15.39.

Today the stock has traded between $171.09 and $191.20. The current price is 2.5% above the day's low and 8.3% below its high.

Volume so far is 2.07M shares, above the average of 529.30K shares a day.

Over the past year DaVita has ranged from $101.00 to $247.49, and now sits 51% of the way up that range.

DaVita met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $4.02 per share against an estimate of $3.92.

The average analyst price target is $224.74, 28.2% above the current price, from 5 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

60%of 5 analyst ratings say Buy
  • Buy60.0%
  • Hold40.0%
  • Sell0.0%
Price target · 9 analystsAvg $224.74
Low
$169.98
Now
$175.35
High
$283.50

DVA earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 7.0% on average.

  1. Q3 FY24: reported $2.50 per share against an estimate of $2.75
  2. Q4 FY24: reported $2.24 per share against an estimate of $2.15
  3. Q1 FY25: reported $2.00 per share against an estimate of $1.97
  4. Q2 FY25: reported $2.95 per share against an estimate of $2.83
  5. Q3 FY25: reported $2.04 per share against an estimate of $3.25
  6. Q4 FY25: reported $3.40 per share against an estimate of $3.19
  7. Q1 FY26: reported $2.87 per share against an estimate of $2.34
  8. Q2 FY26: reported $4.02 per share against an estimate of $3.92

DVA news

  • Press releasePRNewswire

    DaVita Responds to HHS Kidney Care National Plan, Reaffirms Commitment to Innovation, Access and Patient Choice

  • Piero Cingari

    Health Care Stocks Hit Record Highs, GM Drops Nearly 8%: Stock Market Today

  • Press releasePRNewswire

    DaVita Inc. Schedules 3rd Quarter 2026 Investor Conference Call

  • Press releasePRNewswire

    DaVita Brings New Clinical Research to ASN Kidney Week 2026, Advancing Evidence for the Next Era of Kidney Care

  • Press releasePRNewswire

    DaVita Activates Emergency Response Efforts Ahead of Hurricane Isaias, Urges Kidney Patients to Prepare Early

  • Rishabh Mishra

    Michael Burry Warns Anthropic’s Valuation Could Buy 78 Profitable S&P 500 Companies: ‘Fun Game in Times Like These’

  • 10 Health Care Stocks Whale Activity In Today’s Session

  • Chris Katje

    Warren Buffett, Donald Trump Bet on Same 17 Stocks — Some Might Surprise You

Similar companies

Companies in the same industry as DaVita

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.